Page 202 - Genentech News Today

A new, high-tech, sustainable biologics manufacturing facility at Genentech’s US Oceanside campus will be operational in early 2025.

BioPharma

Market Size – USD 2.04 Billion in 2021, Market Growth – at a CAGR of 16.5%, Market Trends – Implementation of new technologies across the globe

Sanofi announced today that Dr. John Reed, its Global Head of R&D, will be leaving the company to pursue a new opportunity outside Sanofi. The company warmly thanks Dr. Reed for his leadership over these last years. Since joining Sanofi in 2018, John has laid the foundation for the company’s R&D transformation. He ...

Alzheimer's disease has a widespread negative impact, affecting patients, families, and society, and early identification and treatment is crucial to mitigate its effects as the number of patients is expected to double by 2050.

The Mayo Clinic on Tuesday released details of its findings by a panel of experts on the benefits of slowing the progression of Alzheimer's disease as a viable treatment in advance of f ...

Many rural and community emergency departments lack access to pediatric specialty care physicians. So, when an acutely ill child is seen in one of these facilities, they are typically transferred to regional pediatric centers for more comprehensive care.

Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis, and Celltrion. The global biosimilar lymphocyte...

/PRNewswire/ -- KeifeRx, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for...

GlaxoSmithKline PLC is a major player in the pharmaceutical and biotechnology industry. Here's a look at the GlaxoSmithKline PLC leaders and executives!